Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Exelixis (EXEL)
NASDAQ:EXEL
Exelixis (EXEL) Stock Price & Analysis
2,608 Followers
EXEL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$14.87 - $22.80
Previous Close$21.48
Volume2.24M
Average Volume (3M)2.21M
Market Cap
$6.84B
Enterprise ValueN/A
Total Cash (Recent Filing)$1.27B
Total Debt (Recent Filing)$194.69M
Price to Earnings (P/E)42.7
Beta0.63
Next Earnings
Oct 31, 2023EPS Estimate
$0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.50
Shares Outstanding318,380,785
10 Day Avg. Volume2,400,735
30 Day Avg. Volume2,211,323
Standard Deviation0.13
R-Squared0.08
Alpha0.00465
Financial Highlights & Ratios
Price to Book (P/B)2.78
Price to Sales (P/S)14.62
Price to Cash Flow (P/CF)20.50
P/FCF Ratio22.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$25.58Price Target Upside19.09% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Exelixis News
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EXEL FAQ
What was Exelixis’s price range in the past 12 months?
Exelixis lowest stock price was $14.87 and its highest was $22.80 in the past 12 months.
What is Exelixis’s market cap?
Currently, no data Available
When is Exelixis’s upcoming earnings report date?
Exelixis’s upcoming earnings report date is Oct 31, 2023 which is in 38 days.
How were Exelixis’s earnings last quarter?
Exelixis released its earnings results on Aug 01, 2023. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.165 by $0.085.
Is Exelixis overvalued?
According to Wall Street analysts Exelixis’s price is currently Undervalued.
Does Exelixis pay dividends?
Exelixis does not currently pay dividends.
What is Exelixis’s EPS estimate?
Exelixis’s EPS estimate is $0.2.
How many shares outstanding does Exelixis have?
Exelixis has 318,380,800 shares outstanding.
What happened to Exelixis’s price movement after its last earnings report?
Exelixis reported an EPS of $0.25 in its last earnings report, beating expectations of $0.165. Following the earnings report the stock price went up 3.617%.
Which hedge fund is a major shareholder of Exelixis?
Among the largest hedge funds holding Exelixis’s share is Farallon Capital Management, L.L.C.. It holds Exelixis’s shares valued at 494M.
---
Exelixis Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$25.58 (19.09% Upside)
$25.58 (19.09% Upside)
Blogger Sentiment
Bullish
EXEL Sentiment 100%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Increased
By 2.6M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.6%
Last 30 Days ▼ 0.9%
Last 30 Days ▼ 0.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.63%
12-Months-Change
Fundamentals
Return on Equity
6.68%
Trailing 12-Months
Asset Growth
9.06%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Exelixis
Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of Cometriq, Cabometyx, and Cotellic. The company was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994 and is headquartered in Alameda, CA.
---
Top 5 ETFs holding EXEL
Vanguard Total Stock Market ETF
$225.70M
Vanguard Russell 1000 Growth ETF
$4.14M
Vanguard Russell 1000 ETF
$1.01M
Vanguard Russell 1000 Value ETF
$790.79K
Vanguard Russell 3000 ETF
$459.31K
Up to five ETFs with an Outperform Smart Score that hold EXEL. The ETFs are listed according to market value of EXEL within the ETF
---